We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
2576
Alnylam Pharmaceuticals
ALNY
$29.3B
$15K ﹤0.01%
149
-5,420
-97% -$538K
CVSA
2577
Covista Inc
CVSA
$4.8B
$15K ﹤0.01%
320
-1,814
-85% -$86.7K
AZN icon
2578
AstraZeneca
AZN
$250B
$15K ﹤0.01%
+212
New +$15.3K
BNDX icon
2579
Vanguard Total International Bond ETF
BNDX
$82.2B
$15K ﹤0.01%
+280
New +$15.3K
CRD.A icon
2580
Crawford & Co Class A
CRD.A
$669M
$15K ﹤0.01%
+1,786
New +$14.3K
CWB icon
2581
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.69B
$15K ﹤0.01%
+281
New +$14.8K
CX icon
2582
Cemex
CX
$16.3B
$15K ﹤0.01%
2,285
-36,534
-94% -$231K
DB icon
2583
Deutsche Bank
DB
$71.5B
$15K ﹤0.01%
+1,400
New +$17.9K
EGAN icon
2584
eGain
EGAN
$201M
$15K ﹤0.01%
+988
New +$10.6K
EPU icon
2585
iShares MSCI Peru and Global Exposure ETF
EPU
$567M
$15K ﹤0.01%
388
+16
+4% +$682
FBRX icon
2586
Forte Biosciences
FBRX
$1.57B
$15K ﹤0.01%
4
+1
+33% +$3.66K
IUSB icon
2587
iShares Core Universal USD Bond ETF
IUSB
$43.1B
$15K ﹤0.01%
+300
New +$14.8K
IWR icon
2588
iShares Russell Mid-Cap ETF
IWR
$57.4B
$15K ﹤0.01%
276
-42,148
-99% -$2.22M
LWAY icon
2589
Lifeway Foods
LWAY
$481M
$15K ﹤0.01%
3,058
+2,517
+465% +$14.1K
METC icon
2590
Ramaco Resources Class A
METC
$649M
$15K ﹤0.01%
2,240
+1,304
+139% +$9.29K
NXJ
2591
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$15K ﹤0.01%
+1,140
New +$14.8K
OLP
2592
One Liberty Properties
OLP
$527M
$15K ﹤0.01%
556
-6,145
-92% -$152K
OMF icon
2593
OneMain Financial
OMF
$7.47B
$15K ﹤0.01%
440
-14,898
-97% -$482K
PHX
2594
DELISTED
PHX Minerals
PHX
$15K ﹤0.01%
+760
New +$15.2K
PTCT icon
2595
PTC Therapeutics
PTCT
$6.12B
$15K ﹤0.01%
442
-6,914
-94% -$216K
RVSB icon
2596
Riverview Bancorp
RVSB
$108M
$15K ﹤0.01%
1,751
-3,374
-66% -$30K
ECHO
2597
EchoStar
ECHO
$26.2B
$15K ﹤0.01%
415
+106
+34% +$4.33K
SGMO
2598
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$15K ﹤0.01%
1,067
-13,333
-93% -$221K
AD
2599
Array Digital Infrastructure
AD
$3.05B
$15K ﹤0.01%
+415
New +$15.7K
LSXMA
2600
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$15K ﹤0.01%
+473
New +$15K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.